89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 50 filers reported holding 89BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $46,577,402 | +119.9% | 3,658,869 | 0.0% | 0.89% | +126.7% |
| Q3 2022 | $21,185,000 | +79.8% | 3,658,869 | 0.0% | 0.39% | +84.5% |
| Q2 2022 | $11,782,000 | -14.6% | 3,658,869 | 0.0% | 0.21% | -4.9% |
| Q1 2022 | $13,794,000 | -71.7% | 3,658,869 | -1.9% | 0.22% | -64.3% |
| Q4 2021 | $48,744,000 | -33.3% | 3,729,442 | 0.0% | 0.63% | -21.9% |
| Q3 2021 | $73,060,000 | +4.8% | 3,729,442 | 0.0% | 0.80% | +13.9% |
| Q2 2021 | $69,741,000 | -21.0% | 3,729,442 | 0.0% | 0.70% | -14.6% |
| Q1 2021 | $88,313,000 | -2.8% | 3,729,442 | 0.0% | 0.83% | +3.9% |
| Q4 2020 | $90,887,000 | -5.0% | 3,729,442 | 0.0% | 0.80% | -33.9% |
| Q3 2020 | $95,697,000 | +19.9% | 3,729,442 | -6.9% | 1.20% | +7.0% |
| Q2 2020 | $79,809,000 | -21.1% | 4,004,442 | 0.0% | 1.12% | -33.8% |
| Q1 2020 | $101,112,000 | -4.0% | 4,004,442 | 0.0% | 1.70% | +13.0% |
| Q4 2019 | $105,277,000 | – | 4,004,442 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $176,277,677 | 3.47% |
| Orchard Capital Management, LLC | 542,879 | $8,382,052 | 3.10% |
| Artia Global Partners LP | 465,465 | $7,186,780 | 2.99% |
| Octagon Capital Advisors LP | 1,219,157 | $18,823,784 | 2.89% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,694,404 | $41,601,598 | 2.25% |
| University of Wisconsin Foundation | 126,516 | $1,953,407 | 2.24% |
| Tri Locum Partners LP | 249,571 | $3,853,376 | 1.23% |
| Endurant Capital Management LP | 82,153 | $1,268,442 | 1.14% |
| Parkman Healthcare Partners LLC | 363,553 | $5,613,258 | 1.03% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,523,000 | 1.02% |